| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 130,691 | 95,818 | 99,751 | | Cost of Revenue | 103,237 | 85,450 | 82,022 | | | Gross Profit | 27,454 | 10,368 | 17,729 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 31,104 | 29,426 | 27,863 | | Non Recurring |
-
| 612 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (3,650) | (19,670) | (10,134) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,205 | 4 |
-
| | Earnings Before Interest And Taxes | 1,555 | (19,666) | (10,134) | | Interest Expense | 3,320 | 3,345 | 2,434 | | Income Before Tax | (1,765) | (23,011) | (12,568) | | Income Tax Expense | 39 | 42 | 43 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,804) | (23,053) | (12,611) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (1,804) | (23,053) | (12,611) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,804) | ($23,053) | ($12,611) |
|
0.83% Nasdaq 0.00%
Income Statement
